CHEBI:194186 - tirzepatide

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name tirzepatide
ChEBI ID CHEBI:194186
Definition A 39-amino acid linear polypeptide which is conjugated to a C20 fatty diacid moiety via a linker connected to lysine-20. It is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 agonist used for the management of type 2 diabetes mellitus.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C225H348N48O68
Net Charge 0
Average Mass 4813.527
Monoisotopic Mass 4810.52486
InChI InChI=1S/C225H348N48O68/c1-23-126(10)183(264-198(311)146(64-50-52-88-226)246-202(315)157(109-180(297)298)252-199(312)152(103-124(6)7)261-223(337)225(21,22)269-217(330)185(128(12)25-3)266-209(322)163(120-278)257-200(313)153(107-138-74-78-141(282)79-75-138)250-203(316)158(110-181(299)300)253-207(320)162(119-277)259-216(329)187(134(18)280)267-206(319)155(106-136-60-44-41-45-61-136)254-215(328)186(133(17)279)262-174(289)114-237-193(306)147(83-87-179(295)296)260-222(336)224(19,20)268-192(305)143(227)104-137-72-76-140(281)77-73-137)214(327)242-131(15)190(303)244-148(80-84-168(228)283)196(309)245-145(65-51-53-89-231-175(290)121-340-100-99-339-97-91-233-176(291)122-341-101-98-338-96-90-232-170(285)86-82-150(221(334)335)243-171(286)70-46-38-36-34-32-30-28-26-27-29-31-33-35-37-39-47-71-178(293)294)195(308)240-130(14)191(304)248-154(105-135-58-42-40-43-59-135)205(318)263-182(125(8)9)212(325)247-149(81-85-169(229)284)197(310)251-156(108-139-111-234-144-63-49-48-62-142(139)144)201(314)249-151(102-123(4)5)204(317)265-184(127(11)24-2)213(326)241-129(13)189(302)236-112-172(287)235-115-177(292)270-92-54-66-164(270)210(323)258-161(118-276)208(321)256-160(117-275)194(307)238-113-173(288)239-132(16)218(331)272-94-56-68-166(272)220(333)273-95-57-69-167(273)219(332)271-93-55-67-165(271)211(324)255-159(116-274)188(230)301/h40-45,48-49,58-63,72-79,111,123-134,143,145-167,182-187,234,274-282H,23-39,46-47,50-57,64-71,80-110,112-122,226-227H2,1-22H3,(H2,228,283)(H2,229,284)(H2,230,301)(H,231,290)(H,232,285)(H,233,291)(H,235,287)(H,236,302)(H,237,306)(H,238,307)(H,239,288)(H,240,308)(H,241,326)(H,242,327)(H,243,286)(H,244,303)(H,245,309)(H,246,315)(H,247,325)(H,248,304)(H,249,314)(H,250,316)(H,251,310)(H,252,312)(H,253,320)(H,254,328)(H,255,324)(H,256,321)(H,257,313)(H,258,323)(H,259,329)(H,260,336)(H,261,337)(H,262,289)(H,263,318)(H,264,311)(H,265,317)(H,266,322)(H,267,319)(H,268,305)(H,269,330)(H,293,294)(H,295,296)(H,297,298)(H,299,300)(H,334,335)/t126-,127-,128-,129-,130-,131-,132-,133+,134+,143-,145-,146-,147-,148-,149-,150+,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,182-,183-,184-,185-,186-,187-/m0/s1
InChIKey BTSOGEDATSQOAF-SMAAHMJQSA-N
SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)C(C)(C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): glucagon-like peptide-1 receptor agonist
An agonist that binds to and activates glucagon-like peptide-1 (GLP-1) receptors.
anti-obesity agent
Any substance which is used to reduce or control weight.
gastric inhibitory polypeptide receptor agonist
An agonist that binds to and activates gastric inhibitory polypeptide (GIP) receptors.
incretin mimetic
Any compound that mimics the action of incretins, gastrointestinal hormones that cause an increase in the amount of insulin released from the beta cells of the islets of Langerhans after eating, even before blood glucose levels become elevated.
Application(s): hypoglycemic agent
A drug which lowers the blood glucose level.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing tirzepatide (CHEBI:194186) has role anti-obesity agent (CHEBI:74518)
tirzepatide (CHEBI:194186) has role gastric inhibitory polypeptide receptor agonist (CHEBI:194187)
tirzepatide (CHEBI:194186) has role glucagon-like peptide-1 receptor agonist (CHEBI:71196)
tirzepatide (CHEBI:194186) has role hypoglycemic agent (CHEBI:35526)
tirzepatide (CHEBI:194186) has role incretin mimetic (CHEBI:64088)
tirzepatide (CHEBI:194186) is a polypeptide (CHEBI:15841)
IUPAC Name
L-tyrosyl-2-methylalanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-tyrosyl-L-seryl-L-isoleucyl-2-methylalanyl-L-leucyl-L-α-aspartyl-L-lysyl-L-isoleucyl-L-alanyl-L-glutaminyl-N6-(17-{[N-(19-carboxynonadecanoyl)-D-γ-glutamyl]amino}-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecanan-1-oyl)-L-lysyl-L-alanyl-L-phenylalanyl-L-valyl-L-glutaminyl-L-tryptophyl-L-leucyl-L-isoleucyl-L-alanylglycylglycyl-L-prolyl-L-seryl-L-serylglycyl-L-alanyl-L-prolyl-L-prolyl-L-prolyl-L-serinamide
Synonyms Sources
LY-3298176 ChEBI
LY3298176 ChEBI
Brand Name Source
Mounjaro KEGG DRUG
Manual Xrefs Databases
D11360 KEGG DRUG
DB15171 DrugBank
Tirzepatide Wikipedia
View more database links
Registry Number Type Source
2023788-19-2 CAS Registry Number ChEBI
Citations Waiting for Citations Types Sources
30293770 PubMed citation Europe PMC
34681215 PubMed citation Europe PMC
34788445 PubMed citation Europe PMC
35333651 PubMed citation Europe PMC
35579691 PubMed citation Europe PMC
35658024 PubMed citation Europe PMC
35759552 PubMed citation Europe PMC
35760842 PubMed citation Europe PMC
35767712 PubMed citation Europe PMC
35773392 PubMed citation Europe PMC
35780672 PubMed citation Europe PMC
35802842 PubMed citation Europe PMC
35807558 PubMed citation Europe PMC
35830001 PubMed citation Europe PMC
35929468 PubMed citation Europe PMC
35949358 PubMed citation Europe PMC
35977865 PubMed citation Europe PMC
35983423 PubMed citation Europe PMC
36050763 PubMed citation Europe PMC
36152638 PubMed citation Europe PMC
36155186 PubMed citation Europe PMC
36157450 PubMed citation Europe PMC
36199834 PubMed citation Europe PMC
36200219 PubMed citation Europe PMC
36239652 PubMed citation Europe PMC
36239653 PubMed citation Europe PMC
36251836 PubMed citation Europe PMC
36313764 PubMed citation Europe PMC
36358930 PubMed citation Europe PMC
36478180 PubMed citation Europe PMC
36498958 PubMed citation Europe PMC
36516422 PubMed citation Europe PMC
36530219 PubMed citation Europe PMC
36569320 PubMed citation Europe PMC
36570276 PubMed citation Europe PMC
36575627 PubMed citation Europe PMC
Last Modified
03 January 2023